Browse drugs

…-term outcomes. Effective preventive strategies remain limited. Liraglutide, a glucagon-like peptide-1 receptor agonist, has demonstrated p…

…her surgery is not viable. This case report outlines the use of liraglutide, a GLP-1 agonist, in the successful management of HOS following…

…intensification or change was 1.6 (0.7) and 1.4 (0.7) years for semaglutide and alternative treatment, with no subgroup differences noted (…

…ever, these studies did not employ suitable active comparators. Metformin is often prescribed as first-line therapy in T2DM management, w…

… with naltrexone-bupropion, oral semaglutide, orforglipron, and tirzepatide (risk ratios from 3.1 to 4.2). Fatigue risk increased, particul…

…s demonstrated that demographic factors, BMI, type of GLP-1 RA (Tirzepatide, Semaglutide and Liraglutide), indication and the presence of d…

…CI −0.53 to 0.86 events per 1000 person-years) or compared with DPP-4is (HR 0.94; 95% CI 0.71 to 1.24, rate difference −0.18; 95% CI −0…

…nsporter 2 inhibitors, and insulin, as well as length of use of metformin, sulfonylureas, thiazolidinediones, dipeptidyl peptidase 4 inhi…

…fects of cagrilintide/semaglutide, liraglutide, semaglutide and tirzepatide in patients with and without a history of HF. The primary outco…

…ced by 25% baseline. No adverse effect was recorded.Conclusions Dexmedetomidine, beyond its sedative properties, offers analgesic effects via α…